NO20013715L - Karbamatderivater av diaryl 1,3,4-oksadiazolon - Google Patents

Karbamatderivater av diaryl 1,3,4-oksadiazolon

Info

Publication number
NO20013715L
NO20013715L NO20013715A NO20013715A NO20013715L NO 20013715 L NO20013715 L NO 20013715L NO 20013715 A NO20013715 A NO 20013715A NO 20013715 A NO20013715 A NO 20013715A NO 20013715 L NO20013715 L NO 20013715L
Authority
NO
Norway
Prior art keywords
oxadiazolone
diaryl
carbamate derivatives
carbamate
derivatives
Prior art date
Application number
NO20013715A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013715D0 (no
Inventor
Piyasena Hewawasam
Xi Chen
Jr John E Starret
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20013715D0 publication Critical patent/NO20013715D0/no
Publication of NO20013715L publication Critical patent/NO20013715L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20013715A 1999-01-29 2001-07-27 Karbamatderivater av diaryl 1,3,4-oksadiazolon NO20013715L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11791399P 1999-01-29 1999-01-29
PCT/US2000/001494 WO2000044745A1 (en) 1999-01-29 2000-01-20 Carbamate derivatives of diaryl 1,3,4-oxadiazolone

Publications (2)

Publication Number Publication Date
NO20013715D0 NO20013715D0 (no) 2001-07-27
NO20013715L true NO20013715L (no) 2001-09-17

Family

ID=22375485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013715A NO20013715L (no) 1999-01-29 2001-07-27 Karbamatderivater av diaryl 1,3,4-oksadiazolon

Country Status (18)

Country Link
US (1) US6162817A (hu)
EP (1) EP1150978A4 (hu)
JP (1) JP2002535402A (hu)
KR (1) KR20010101869A (hu)
CN (1) CN1133636C (hu)
AU (1) AU771471B2 (hu)
BR (1) BR0007255A (hu)
CA (1) CA2358964A1 (hu)
CZ (1) CZ20012712A3 (hu)
HU (1) HUP0200089A3 (hu)
ID (1) ID29269A (hu)
IL (1) IL144540A0 (hu)
NO (1) NO20013715L (hu)
NZ (1) NZ512077A (hu)
PL (1) PL349097A1 (hu)
TR (1) TR200102070T2 (hu)
WO (1) WO2000044745A1 (hu)
ZA (1) ZA200104304B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297241B1 (en) * 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
CA2425771A1 (en) * 2000-10-13 2002-04-18 Christopher G. Boissard Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (hu) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
DK1056754T3 (da) * 1998-01-29 2004-02-16 Bristol Myers Squibb Co Phosphatderivater af diaryl-1,3,4-oxadiazolon
AU735704B2 (en) * 1998-01-29 2001-07-12 Bristol-Myers Squibb Company Derivatives of 1,3,4-oxadiazolone
US5977150A (en) * 1998-01-29 1999-11-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone
JP2002501912A (ja) * 1998-01-29 2002-01-22 ブリストル−マイヤーズ スクイブ カンパニー ジアリール１、３、４−オキサジアゾロンのベンゾエート誘導体

Also Published As

Publication number Publication date
NO20013715D0 (no) 2001-07-27
CA2358964A1 (en) 2000-08-03
ID29269A (id) 2001-08-16
AU2970000A (en) 2000-08-18
EP1150978A4 (en) 2002-06-12
CZ20012712A3 (cs) 2001-10-17
EP1150978A1 (en) 2001-11-07
US6162817A (en) 2000-12-19
HUP0200089A3 (en) 2004-07-28
WO2000044745A1 (en) 2000-08-03
IL144540A0 (en) 2002-05-23
NZ512077A (en) 2003-07-25
CN1133636C (zh) 2004-01-07
ZA200104304B (en) 2002-01-24
AU771471B2 (en) 2004-03-25
KR20010101869A (ko) 2001-11-15
JP2002535402A (ja) 2002-10-22
BR0007255A (pt) 2001-09-25
HUP0200089A2 (hu) 2002-05-29
PL349097A1 (en) 2002-07-01
TR200102070T2 (tr) 2001-12-21
CN1336926A (zh) 2002-02-20

Similar Documents

Publication Publication Date Title
MA26816A1 (fr) Derives d'amino-triazolopyridine
DE69907964D1 (de) 1,2-annelierte chinolinderivate
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
DE69900356D1 (de) Nitro-Isoharnstoffderivate
DE59911978D1 (de) Carbamatlösungen
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
PT1140835E (pt) Derivados da 3,3-biarilpiperidina e 2,2-biarilmorfolina
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
FR2791043B3 (fr) Pulverisateur d'assaisonnement
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
MA27240A1 (fr) Derives d'imidazoquinoleine
NO20013715D0 (no) Karbamatderivater av diaryl 1,3,4-oksadiazolon
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
ATE243218T1 (de) 2''-deoxyhygromycinderivate
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
ID27331A (id) Pembuatan antibiotik-antibiotik ketolida karbamat
MA26481A1 (fr) Derives d'arylsecocholadiene
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
DE69815244D1 (de) Galactosylierte hydroxyalkylpolysaccharide und ihre derivate
UA3169S (uk) Печиво "талісман"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application